L'expertise scientifique

logo

Référence :

  • O065. Thouvenot É et al. High-dose cholecalciferol reduces multiple sclerosis disease activity after a clinically isolated syndrome: results of a 24-month placebo-controlled randomized trial (D-lay MS). Ectrims 2024.